Ultracet and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ultracet (acetaminophen; tramadol hydrochloride) and Keppra (levetiracetam). Common drug interactions include diabetes mellitus among females and ileus among males.

The phase IV clinical study analyzes what interactions people have when they take Ultracet and Keppra. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Ultracet?

Ultracet has active ingredients of acetaminophen; tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 6,351 Ultracet users. Check the latest studies of Ultracet.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.



On Jul, 14, 2026

27 people who take Ultracet and Keppra together, and have interactions are studied.

Ultracet and Keppra drug interactions.

What are the common drug interactions of Ultracet and Keppra, by gender? *:

female:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Vertigo
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Depression
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dyspnoea (difficult or laboured respiration)
  7. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

male:

  1. Ileus (a painful obstruction of the ileum or other part of the intestine)
  2. Pneumonia
  3. Confusional state
  4. Death
  5. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  6. Malignant neoplasm progression (cancer tumour came back)
  7. Thrombosis (formation of a blood clot inside a blood vessel)

What are the common drug interactions of Ultracet and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Obesity (having too much body fat)
  2. Type 2 diabetes mellitus

30-39:

  1. Acute respiratory failure
  2. Anxiety
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Dizziness
  7. Drug ineffective
  8. Foot fracture
  9. Headache (pain in head)
  10. Migraine (headache)

40-49:

  1. Abdominal pain
  2. Chest pain
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Non-cardiac chest pain
  5. Renal failure (kidney dysfunction)
  6. Abdominal pain upper
  7. Anaemia (lack of blood)
  8. Anxiety disorder
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

50-59:

  1. Acquired oesophageal web (structural abnormalities in the oesophagus)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Ankle fracture
  4. Arteriosclerosis (thickening and hardening of arteries)
  5. Asthma
  6. Blindness
  7. Blood pressure fluctuation
  8. Breast disorder
  9. Anxiety
  10. Insomnia (sleeplessness)

60+:

  1. Ileus (a painful obstruction of the ileum or other part of the intestine)
  2. Pneumonia
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Tooth disorder (tooth disease)
  6. Tooth fracture
  7. Abdominal distension
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Death
  10. Dental caries

What are the existing conditions these people have? *

  1. Depression: 6 people, 22.22%
  2. Stress And Anxiety: 4 people, 14.81%
  3. Nausea And Vomiting: 3 people, 11.11%
  4. Migraine (headache): 3 people, 11.11%
  5. Intervertebral Disc Degeneration (spinal disc degeneration): 3 people, 11.11%
  6. Dissociative Disorder: 3 people, 11.11%
  7. Hypersensitivity: 3 people, 11.11%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.11%
  9. Glossitis (infection of tongue with soreness): 3 people, 11.11%
  10. Headache (pain in head): 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Ultracet and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ultracet and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ultracet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultracet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; tramadol hydrochloride and levetiracetam (the active ingredients of Ultracet and Keppra, respectively), and Ultracet and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: